We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

118 hedge funds and large institutions have $2.73B invested in Maravai LifeSciences in 2020 Q4 according to their latest regulatory filings, with 118 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,490% more call options, than puts

Call options by funds: $5.21M | Put options by funds: $328K

100.83% more ownership

Funds ownership: 0% → 100.83% (+101%)

Holders
118
Holders Change
+118
Holders Change %
–
% of All Funds
2.09%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.09%
New
118
Increased
–
Reduced
–
Closed
–
Calls
$5.21M
Puts
$328K
Net Calls
+$4.89M
Net Calls Change
+$4.89M

Top Buyers

Rank Fund Capital Flow
1
DCP
D1 Capital Partners
New York
+$165M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$159M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$131M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$118M
5
JP Morgan Chase
JP Morgan Chase
New York
+$115M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GL
1
GTCR LLC
Illinois
$775M +$770M +27,646,515 New
DCP
2
D1 Capital Partners
New York
$166M +$165M +5,930,000 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$160M +$159M +5,706,562 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$132M +$131M +4,713,452 New
Massachusetts Financial Services
5
Massachusetts Financial Services
Massachusetts
$119M +$118M +4,236,607 New
JP Morgan Chase
6
JP Morgan Chase
New York
$116M +$115M +4,140,989 New
Invesco
7
Invesco
Georgia
$111M +$110M +3,951,436 New
UBS AM
8
UBS AM
Illinois
$106M +$105M +3,763,012 New
APM
9
Avidity Partners Management
Texas
$96.7M +$96M +3,445,772 New
Lazard Asset Management
10
Lazard Asset Management
New York
$95.8M +$95.1M +3,415,297 New
HM
11
HealthCor Management
New York
$87.9M +$87.3M +3,134,712 New
BlackRock
12
BlackRock
New York
$60.9M +$60.4M +2,170,563 New
WRF
13
Waddell & Reed Financial
Kansas
$58.4M +$58M +2,081,210 New
Franklin Resources
14
Franklin Resources
California
$51.9M +$51.5M +1,849,405 New
Holocene Advisors
15
Holocene Advisors
New York
$36.5M +$36.3M +1,302,128 New
ClearBridge Investments
16
ClearBridge Investments
New York
$33.8M +$33.6M +1,205,255 New
Citadel Advisors
17
Citadel Advisors
Florida
$32.9M +$32.7M +1,173,529 New
Allianz Asset Management
18
Allianz Asset Management
Germany
$31.3M +$31.1M +1,116,350 New
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$29.7M +$29.5M +1,060,408 New
Balyasny Asset Management
20
Balyasny Asset Management
Illinois
$28M +$27.8M +998,671 New
SAM
21
Sectoral Asset Management
Quebec, Canada
$27.4M +$27.3M +978,600 New
Janus Henderson Group
22
Janus Henderson Group
United Kingdom
$23M +$22.8M +820,275 New
Millennium Management
23
Millennium Management
New York
$19.8M +$19.7M +705,698 New
CCM
24
CAAS Capital Management
New York
$19.6M +$19.5M +700,000 New
Fidelity International
25
Fidelity International
Bermuda
$18.5M +$18.3M +658,353 New
1
2 3 4 5

MRVI Hedge Fund Activity: Q4 2020 in Review

118 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q4 2020, worth a combined $2.73B.

Buyers outnumbered sellers: 118 funds opened new MRVI positions and 0 closed out — a net gain of 118 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was D1 Capital Partners, opening a new position worth an estimated $165M.

  • 118 institutional investors held Maravai LifeSciences (MRVI) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $2.73B of Maravai LifeSciences stock for Q4 2020.
  • 118 funds opened new Maravai LifeSciences positions in Q4 2020 and 0 closed out, a net change of +118 holders.
  • The largest Maravai LifeSciences buyer in Q4 2020 was D1 Capital Partners, an estimated $165M added.

Based on aggregated 13F filings for Q4 2020.